Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 789 full-time employees The company went IPO on 2013-05-07. The firm operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for BJTRF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: BJTRF is a Buy candidate.
BJTRF stock price ended at $0.65 on 星期三, after rising 0.00%
On the latest trading day Jan 28, 2026, the stock price of BJTRF rose by 0.00%, climbing from $0.65 to $0.65. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.65 and a high of $0.65. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 400 shares were traded, equating to a market value of approximately $544.1M.